ContractCo-Ownership Agreement • January 19th, 2021 • Biophytis SA • Pharmaceutical preparations
Contract Type FiledJanuary 19th, 2021 Company IndustryPORTIONS OF THIS EXHIBIT IDENTIFIED BY [*****] HAVE BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE EXCLUDED INFORMATION IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
CO-OWNERSHIP AGREEMENTCo-Ownership Agreement • January 19th, 2021 • Biophytis SA • Pharmaceutical preparations
Contract Type FiledJanuary 19th, 2021 Company IndustryConsidering the beneficiary contract no. ANR-10-SATT-04-01 signed between the Agence Nationale de la Recherche, Université Pierre et Marie Curie, Université de technologie de Compïègne, Université Panthéon Assas, institut Européen d’Administration des Affaires and Centre National de la Recherche Scientifique [National Centre for Scientific Research], in the presence of the Caisse des Dépôts et Consignation [Bank for Official Deposits] on 17 January 2012;
CO-OWNERSHIP AGREEMENT CONSIDERED AS PARTIAL TRANSFER OF SHARE OF PATENTCo-Ownership Agreement • January 19th, 2021 • Biophytis SA • Pharmaceutical preparations
Contract Type FiledJanuary 19th, 2021 Company IndustryHereinafter referred to as “INRA”, having its registered office at 147, rue de Université 75338 PARIS CEDEX 07 — France, here represented by Mr Philippe MAUGUIN, in his capacity as President, and by delegation by Ms Nathalie MORCRETTE in her capacity as Secretary General of the Directorate of the Partnership and the Transfer for innovation (DPTI).
CO-OWNERSHIP AGREEMENTCo-Ownership Agreement • November 20th, 2020 • Biophytis SA • Pharmaceutical preparations
Contract Type FiledNovember 20th, 2020 Company IndustryConsidering the beneficiary contract no. ANR-10-SATT-04-01 signed between the Agence Nationale de la Recherche, Université Pierre et Marie Curie, Université de technologie de Compïègne, Université Panthéon Assas, institut Européen d’Administration des Affaires and Centre National de la Recherche Scientifique [National Centre for Scientific Research], in the presence of the Caisse des Dépôts et Consignation [Bank for Official Deposits] on 17 January 2012;
CO-OWNERSHIP AGREEMENT CONSIDERED AS PARTIAL TRANSFER OF SHARE OF PATENTCo-Ownership Agreement • November 20th, 2020 • Biophytis SA • Pharmaceutical preparations
Contract Type FiledNovember 20th, 2020 Company IndustryHereinafter referred to as “INRA”, having its registered office at 147, rue de Université 75338 PARIS CEDEX 07 — France, here represented by Mr Philippe MAUGUIN, in his capacity as President, and by delegation by Ms Nathalie MORCRETTE in her capacity as Secretary General of the Directorate of the Partnership and the Transfer for innovation (DPTI).
ContractCo-Ownership Agreement • November 20th, 2020 • Biophytis SA • Pharmaceutical preparations
Contract Type FiledNovember 20th, 2020 Company IndustryPORTIONS OF THIS EXHIBIT IDENTIFIED BY [*****] HAVE BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE EXCLUDED INFORMATION IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
CO-OWNERSHIP AGREEMENTCo-Ownership Agreement • May 22nd, 2019 • Biophytis SA • Pharmaceutical preparations
Contract Type FiledMay 22nd, 2019 Company IndustryConsidering the beneficiary contract no. ANR-10-SATT-04-01 signed between the Agence Nationale de la Recherche, Université Pierre et Marie Curie, Université de technologie de Compïègne, Université Panthéon Assas, institut Européen d’Administration des Affaires and Centre National de la Recherche Scientifique [National Centre for Scientific Research], in the presence of the Caisse des Dépôts et Consignation [Bank for Official Deposits] on 17 January 2012;
ContractCo-Ownership Agreement • May 22nd, 2019 • Biophytis SA • Pharmaceutical preparations
Contract Type FiledMay 22nd, 2019 Company IndustryPORTIONS OF THIS EXHIBIT IDENTIFIED BY [*****] HAVE BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE EXCLUDED INFORMATION IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
CO-OWNERSHIP AGREEMENT CONSIDERED AS PARTIAL TRANSFER OF SHARE OF PATENTCo-Ownership Agreement • May 22nd, 2019 • Biophytis SA • Pharmaceutical preparations
Contract Type FiledMay 22nd, 2019 Company IndustryHereinafter referred to as “INRA”, having its registered office at 147, rue de Université 75338 PARIS CEDEX 07 — France, here represented by Mr Philippe MAUGUIN, in his capacity as President, and by delegation by Ms Nathalie MORCRETTE in her capacity as Secretary General of the Directorate of the Partnership and the Transfer for innovation (DPTI).